Discover how KRG's strategic initiatives and strong financial metrics are driving its success in the competitive real estate market.
Discover key insights from Sarepta Therapeutics' Q1 2024 earnings, including significant revenue increases and promising developments in drug approvals and market expansions.
Avnet reports robust sales and operational achievements amidst a tough quarter, with strategic insights on future financial maneuvers and market expectations.